Media center

Meitar Represented PrimeSence, 3D sensing technology developer company, in its acquisition by a multinational corporation.

Meitar represented Conduit in its spin-off of ClientConnect, Conduit’s toolbar division, and the subsequent purchase of ClientConnect by Perion Network Ltd., a NASDAQ company, in an all stock transaction. Conduit’s shareholders and option holders received 81% of Perion shares in the transaction, which closed in January 2014.

Meitar represented NYSE-listed Covidien, a US medical device manufacture, in its acquisition of Given Imaging, a medical technology company that develops and manufactures the swallowable imaging capsules for endoscopy, for approximately $1 billion.

Meitar represented the baby food importer Heinz – Remedia and the former CEO of the company in criminal proceedings involving charges of involuntary manslaughter arising from allegations of tainted baby formula. After five years of litigation, the court acquitted the former CEO of all charges relating to the baby formula. The State has filed an appeal of the acquittal, which is still pending.

Our firm represented Barclays Capital Inc. and Citigroup Global Markets Inc. in the $1.4 billion global notes offering by Israel Electric Corporation.

In July 2013, an Israeli court ruled in favor of the Bronner brothers, represented by Meitar, in a complex inheritance dispute with their siblings, which is a part of a broader dispute involving a worldwide diamond and real-estate business.

Our firm represented J.P Morgan Securities, Merrill Lynch and several other underwriters in the $127 million initial public offering by Wix.com, including both primary and secondary shares, on NASDAQ.